PPARG and breast cancer: 3.9. Effects of γ-Tocotrienol, Rosiglitazone, and GW9662 Treatment Alone or in Combination on COX-2 and PGDS in PPARγ siRNA Transfected PPARγ Positive MCF-7 and MDA-MB-231 Human Breast Cancer Cells